Abstract
To reveal conformational changes resulting in the formation of insulin fibrils, it is necessary to identify amyloidogenic regions in the structure of protein monomers. Different models of insulin fibrillogenesis have been proposed previously. However, precise regions responsible for the formation of amyloid fibrils have not been identified. Using bioinformatics programs for predicting amyloidogenic regions, we have determined some common amyloidogenic sequences in the structure of insulin monomers. The use of limited proteolysis and mass spectrometry analysis of the obtained protein fragments resistant to the action of proteases allowed us to identify amino acid sequences in the insulin structure that can form the spine of the insulin fibrils. The obtained results are in agreement with the earlier proposed model of fibril formation from the ring-like oligomers and can be used for designing insulin analogs resistant to amyloidogenesis.
Similar content being viewed by others
Abbreviations
- a.a.:
-
amino acid residue
- LC-MS:
-
liquid chromatography/mass spectrometry
- m/z :
-
mass-to-charge ratio
References
Kelly, J. W. (1996) Alternative conformations of amyloido–genic proteins govern their behavior, Curr. Opin. Struct. Biol., 6, 11–17.
Dobson, C. M. (2001) Protein folding and its links with human disease, Biochem. Soc. Symp., 68, 1–26.
Galzitskaia, O. V., Garbuzinskii, S. A., and Lobanov, M. Iu. (2006) A search for amyloidogenic regions in protein chain, Mol. Biol. (Moscow), 40, 910–918.
Sipe, J. D., Benson, M. D., Buxbaum, J. N., Ikeda, S., Merlini, G., Saraiva, M. J., and Westermark, P. (2012) Amyloid fibril protein nomenclature: 2012 recommenda–tions from the Nomenclature Committee of the International Society of Amyloidosis, Amyloid, 19, 167–170.
O’Donnell, C. W., Waldispuhl, J., Lis, M., Halfmann, R., Devadas, S., Lindquist, S., and Berger, B. (2011). A method for probing the mutational landscape of amyloid structure, Bioinformatics, 27, 34–42.
Sanger, F., and Tuppy, H. (1951) The amino–acid sequence in the phenylalanyl chain of insulin. 1. The identification of lower peptides from partial hydrolysates, Biochem. J., 49, 463–481.
Sanger, F., and Tuppy, H. (1951) The amino–acid sequence in the phenylalanyl chain of insulin. 2. The investigation of peptides from enzymic hydrolysates, Biochem. J., 49, 481–490.
Waugh, D. F. (1941) The properties of protein fibers pro–duced reversibly from soluble protein molecules, Am. J. Physiol., 133, 484–485.
Klunk, W. E., Pettegrew, J. W., and Abraham, D. J. (1989) Quantitative evaluation of congo red binding to amyloid–like proteins with a beta–pleated sheet conformation, J. Histochem. Cytochem., 37, 1273–1281.
Brange, J., Andersen, L., Laursen, E. D., Meyn, G., and Rasmussen, E. (1997) Toward understanding insulin fibril–lation, J. Pharm. Sci., 86, 517–525.
Selivanova, O. M., Grishin, S. Yu., Glyakina, A. V., Sadgyan, A. S., Ushakova, N. I., and Galzitskaya, O. V. (2018) Analysis of insulin analogs and the strategy of their further development, Biochemistry (Moscow), 83, 146–162.
Baker, E. N., Blundell, T. L., Cutfield J. F., Cutfield, S. M., Dodson, E. J., Dodson, G. G., Hodgkin, D. M. C., Hubbard, R. E., Isaacs, N. W., Reynolds, C. D., Sakabe, K., Sakabe, N., and Vijayan, N. M. (1988) The structure of 2Zn pig insulin crystals at 1.5 Å resolution, Philos. Trans. R. Soc. Lond. B Biol. Sci., 319, 369–456.
Cutfield, J. F., Cutfield, S. M., Dodson, E. J., Dodson, G. G., Emdin, S. F., and Reynolds, C. D. (1979) Structure and biological activity of hagfish insulin, J. Mol. Biol., 132, 85–100.
Frankær, C. G., Sonderby, P., Bang, M. B., Mateiu, R. V., Groenning, M., Bukrinski, J., and Harris, P. (2017) Insulin fibrillation: the influence and coordination of Zn2+, J. Struct. Biol., 199, 27–38.
Phillips, N. B., Whittaker, J., Ismail–Beigi, F., and Weiss, M. A. (2012) Insulin fibrillation and protein design: topo–logical resistance of single–chain analogs to thermal degra–dation with application to a pump reservoir, J. Diabetes Sci. Technol., 6, 277–288.
Nielsen, L., Frokjaer, S., Brange, J., Uversky, V. N., and Fink, A. L. (2001) Probing the mechanism of insulin fibril formation with insulin mutants, Biochemistry, 40, 8397–8409.
Ahmad, A., Millett, I. S., Doniach, S., Uversky, V. N., and Fink, A. L. (2003) Partially folded intermediates in insulin fibrillation, Biochemistry, 42, 11404–11416.
Vestergaard, B., Groenning, M., Roessle, M., Kastrup, J. S., Weert, M., Flink, J. M., Frokjaer, S., Gajhede, M., and Svergun, D. I. (2007) A helical structural nucleus is the pri–mary elongating unit of insulin amyloid fibrils, PLoS Biol., 5, 134–146.
Jimenez, J. L., Nettleton, E. J., Bouchard, M., Robinson, C. V., Dobson, C. M., and Saibil, H. R. (2002) The protofilament structure of insulin amyloid fibrils, Proc. Natl. Acad. Sci. USA, 99, 9196–9201.
Kajava, A. V., Baxa, U., and Steven, A. C. (2010) β–Arcades: recurring motifs in naturally occurring and dis–ease–related amyloid fibrils, FASEB J., 24, 1311–1319.
Selivanova, O. M., Suvorina, M. Y., Surin, A. K., Dovidchenko, N. V., and Galzitskaya, O. V. (2017) Insulin and lispro insulin: what is common and different in their behavior? Curr. Protein Pept. Sci., 18, 57–64.
Meersman, F., and Dobson, C. M. (2006) Probing the pressure–temperature stability of amyloid fibrils provides new insights into their molecular properties, Biochim. Biophys. Acta, 1764, 452–460.
Malisauskas, M., Weise, C., Yanamandra, K., Wolf–Watz, M., and Morozova–Roche, L. (2010) Lability landscape and protease resistance of human insulin amyloid: a new insight into its molecular properties, J. Mol. Biol., 396, 60–74.
Kheterpal, I., Williams, A., Murphy, C., Bledsoe, B., and Wetzel, R. (2001) Structural features of the Abeta amyloid fibril elucidated by limited proteolysis, Biochemistry, 40, 11757–11767.
Piejko, M., Dec, R., Babenko, V., Hoang, A., Szewczyk, M., Mak, P., and Dzwolak, W. (2015) Highly amyloido–genic two–chain peptide fragments are released upon partial digestion of insulin with pepsin, J. Biol. Chem., 290, 5947–5958.
Surin, A. K., Grigorashvili, E. I., Suvorina, M. Y., Selivanova, O. M., and Galzitskaya, O. V. (2016) Determination of regions involved in amyloid fibril formation for Aβ(1–40) peptide, Biochemistry (Moscow), 81, 762–769.
Selivanova, O. M., Suvorina, M. Y., Dovidchenko, N. V., Eliseeva, I. A., Surin, A. K., Finkelstein, A. V., Schmatchenko, V. V., and Galzitskaya, O. V. (2014) How to determine the size of folding nuclei of protofibrils from the concentration dependence of the rate and lag–time of aggregation. II. Experimental application for insulin and LysPro insulin: aggregation morphology, kinetics, and sizes of nuclei, J. Phys. Chem. B, 118, 1198–1206.
Porter, R. R. (1953) Partition chromatography of insulin and other proteins, Biochem. J., 53, 320–328.
Garbuzynskiy, S. O., Lobanov, M. Y., and Galzitskaya, O. V. (2010) FoldAmyloid: a method of prediction of amy–loidogenic regions from protein sequence, Bioinformatics, 26, 326–332.
Ahmed, A. B., Znassi, N., Chateau, M.–T., and Kajava, A. V. (2015) A structure–based approach to predict predisposi–tion to amyloidosis, Alzheimers Dement., 11, 681–690.
Trovato, A., Seno, F., and Tosatto, S. C. E. (2007) The PASTA server for protein aggregation prediction, Protein Eng. Des. Sel., 20, 521–523.
Walsh, I., Seno, F., Tosatto, S. C. E., and Trovato, A. (2014) PASTA 2.0: an improved server for protein aggrega–tion prediction, Nucleic Acids Res., 42, 301–307.
Maurer–Stroh, S., Debulpaep, M., Kuemmerer, N., Lopez de la Paz, M., Martins, I. C., Reumers, J., Morris, K. L., Copland, A., Serpell, L., Serrano, L., Schymkowitz, J. W. H., and Rousseau, F. (2010) Exploring the sequence deter–minants of amyloid structure using position–specific scor–ing matrices, Nat. Methods, 7, 237–242.
Conchillo–Sole, O., de Groot, N. S., Aviles, F. X., Vendrell, J., Daura, X., and Ventura, S. (2007) AGGRESCAN: a server for the prediction and evaluation of “hot spots” of aggregation in polypeptides, BMC Bioinformatics, 8, 1–17.
Zurdo, J., Guijarro, J. I., and Dobson, C. M. (2001) Preparation and characterization of purified amyloid fib–rils, J. Am. Chem. Soc., 123, 8141–8142.
Galzitskaya, O. V., and Selivanova, O. M. (2017) Rosetta stone for amyloid fibrils: the key role of ring–like oligomers in amyloidogenesis, J. Alzheimers Dis., 59, 785–795.
Olsen, J. V., Ong, S. E., and Mann, M. (2004) Trypsin cleaves exclusively C–terminal to arginine and lysine residues, Mol. Cell. Proteomics, 3, 608–614.
Appel, W. (1986) Chymotrypsin: molecular and catalytic properties, Clin. Biochem., 19, 317–322.
Kraus, E., Kiltz, H. H., and Femfert, U. F. (1976) The specificity of proteinase K against oxidized insulin B chain, Hoppe Seylers Z. Physiol. Chem., 357, 233–237.
Morihara, K., and Tszuki, H. (1975) Specificity of pro–teinase K from Tritirachium album limber for synthetic pep–tides, Agricult. Biol. Chem., 39, 1489–1492.
Polverino de Laureto, P., Taddei, N., Frare, E., Capanni, C., Costantini, S., Zurdo, J., Chiti, F., Dobson, C. M., and Fontana, A. (2003) Protein aggregation and amyloid fibril formation by an SH3 domain probed by limited proteolysis, J. Mol. Biol., 334, 129–141.
Selivanova, O. M., and Galzitskaya, O. V. (2012) Structural polymorphism and possible pathways of amyloid fibril for–mation on the example of insulin protein, Biochemistry (Moscow), 77, 1237–1247.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in Russian in Biokhimiya, 2019, Vol. 84, No. 1, pp. 128–137.
Rights and permissions
About this article
Cite this article
Surin, A.K., Grishin, S.Y. & Galzitskaya, O.V. Identification of Amyloidogenic Regions in the Spine of Insulin Fibrils. Biochemistry Moscow 84, 47–55 (2019). https://doi.org/10.1134/S0006297919010061
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297919010061